跳至主要内容
临床试验/ISRCTN77346223
ISRCTN77346223已完成不适用

Acute lymphoblastic leukaemia (ALL) trial XII (joint trial with Eastern Co-operative Oncology Group - E2993)

Medical Research Council (MRC) (UK)0 个研究点目标入组 550 人开始时间: 2000年10月25日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
550

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

性别
All

入选标准

  • 1. Adult patients between 15 and 55 years with previously untreated ALL
  • 2. Morphological proof of ALL
  • 3. Diagnosis has been made from bone marrow morphology with greater than 25% lymphoblasts by the French-American-British (FAB) criteria

排除标准

  • 1. Prior malignancy for which chemotherapy or radiotherapy have been given
  • 2. AML, MDS or other antecedent haematological disorder or lymphoid transformation of chronic myeloid leukaemia
  • 3. Previously treated
  • 4. Intercurrent life threatening disease
  • 5. Pregnant or lactating

研究者

发起方
Medical Research Council (MRC) (UK)

相似试验

Acute lymphoblastic leukaemia (ALL) trial XII (joint... | 临床试验